Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics
Frontiers in Cardiovascular Medicine · 22.08.2024 · 11
DOI: 10.3389/fcvm.2024.1445739 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 22.08.2024. Verfasst von Yan Sun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Research and Translational Medicine, Masonic Medical Research Institute, Utica, NY, United States. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 160 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Protein Tyrosine Phosphatase 1B (PTP1B) has emerged as a significant regulator of metabolic and cardiovascular disease. It is a non-transmembrane protein tyrosine phosphatase that negatively regulates multiple signaling pathways integral to the regulation of growth, survival, and differentiation of cells, including leptin and insulin signaling, which are critical for development of obesity, insulin resistance, type 2 diabetes, and cardiovascular disease. Given PTP1B's central role in glucose homeostasis, energy balance, and vascular function, targeted inhibition of PTP1B represents a promising strategy for treating these diseases. However, challenges, such as off-target effects, necessitate a focus on tissue-specific approaches, to maximize therapeutic benefits while minimizing adverse outcomes. In this review, we discuss molecular mechanisms by which PTP1B influences metabolic and cardiovascular functions, summarize the latest research on tissue-specific roles of PTP1B, and discuss the potential for PTP1B inhibitors as future therapeutic agents.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biomedical Research and Translational Medicine, Masonic Medical Research Institute, Utica, NY, United States.
- Department of Medicine, Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, United States.
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States.
Zitieren
APA
Sun, Y., Dinenno, F. A., Tang, P., & Kontaridis, M. I. (2024). Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics. Frontiers in Cardiovascular Medicine, 11. https://doi.org/10.3389/fcvm.2024.1445739
Vancouver
Sun Y, Dinenno FA, Tang P, Kontaridis MI. Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics. Frontiers in Cardiovascular Medicine. 2024;11. doi:10.3389/fcvm.2024.1445739
BibTeX
@article{Sun2024,
author = {Sun, Yan and Dinenno, Frank A and Tang, Peiyang and Kontaridis, Maria I},
title = {Protein tyrosine phosphatase 1B in metabolic and cardiovascular diseases: from mechanisms to therapeutics},
journal = {Frontiers in Cardiovascular Medicine},
year = {2024},
volume = {11},
doi = {10.3389/fcvm.2024.1445739}
}
EUVIMED